Literature DB >> 24907156

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course.

Koray Tascilar1, Melike Melikoglu2, Serdal Ugurlu1, Necdet Sut1, Erkan Caglar1, Hasan Yazici1.   

Abstract

OBJECTIVE: Some features of Behçet's syndrome (BS) tend to go together. We aimed to explore the association and timing of various vascular events in both the venous and the arterial vascular tree.
METHODS: We conducted a chart survey on the type and time of vascular involvement of BS. The cross-relationships of involvement were assessed by phi correlation coefficients. Multiple correspondence analysis was used to identify patterns of vascular involvement. The risk of vascular recurrence was also estimated.
RESULTS: We identified 882 patients with vascular involvement among 5970 BS patients (14.7%). Deep vein thrombosis (DVT), almost always in the legs, was the most frequent single vascular event (592/882; 67.1%). The cumulative risk of a recurrent vascular event was 38.4% at 5 years. Patients with extrapulmonary artery involvement (EPAI) were significantly older than those with venous and pulmonary artery involvement (PAI). There were significant correlations between dural sinus thrombosis (DST) and PAI, Budd-Chiari syndrome (BCS) and inferior vena cava syndrome (IVCS) and between IVCS and superior vena cava syndrome (SVCS). Multiple correspondence analysis further indicated clustering of PAI, DST, BCS, IVCS and SVCS. However, EPAI and DVT clustered separately from forms of vascular disease, the separate clustering of the DVT being attributed to its propensity to occur solo.
CONCLUSION: The most common type of vascular involvement in BS is solo DVT, almost always occurring in the legs. Various forms of venous disease in BS segregate together and PAI is included in this group. EPAI segregates separately.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Behçet’s syndrome; arterial aneurysm; dural sinus thrombosis; pulmonary artery aneurysm; venous thrombosis

Mesh:

Year:  2014        PMID: 24907156     DOI: 10.1093/rheumatology/keu233

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  36 in total

Review 1.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

2.  Hemoptysis in Behçet's syndrome: from bedside to bench?

Authors:  Giovanni Maria Rossi; Giacomo Emmi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2018-05-07       Impact factor: 3.397

Review 3.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

Review 4.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

5.  Successful management of a giant dissecting aortic aneurysm in a patient with Behcet's disease.

Authors:  Zhiqi Zhang; Kanhua Yin; Yi Lin; Changfa Guo; Yongxin Sun; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 6.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 7.  Neurological complications of Behçet's syndrome.

Authors:  D P Kidd
Journal:  J Neurol       Date:  2017-03-10       Impact factor: 4.849

8.  Behçet's Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association.

Authors:  Clarissa de Albuquerque Botura; Luiz Eduardo Bersani-Amado; Antônio Rubens Zacarias-Júnior; Sueli Donizete Boreli; Naiene Gomes Gordo Stecca; Bruno Ambrósio da Rocha; Roberto Kenji Nakamura Cuman; Ciomar Aparecida Bersani-Amado
Journal:  Clin Med Res       Date:  2018-04-02

Review 9.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

Review 10.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.